Research on D-chiro-inositol for PCOS support is an active area of scientific interest, though the direct evidence available here is limited to a single published trial protocol — the MYPP trial — which has not yet produced results. This registered multicenter randomized controlled trial is designed to investigate myo-inositol (a related compound) rather than D-chiro-inositol specifically, focusing on pregnancy outcomes in women with PCOS rather than broader PCOS symptom management. Studies indicate that earlier trials in general populations suggested potential benefits of myo-inositol for reducing gestational complications, with post-hoc analyses hinting at particular relevance for women with PCOS, but these findings have not yet been confirmed in a dedicated trial. Given that the available evidence here consists solely of a study protocol with no reported outcomes, and that the research addresses a related rather than identical compound, meaningful conclusions about D-chiro-inositol's effects on PCOS based on this source alone cannot be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| MYPP trial: Myo-inositol supplementation to prevent pregnancy complications i... | Other | 2025 | Neutral | 90 |